Shenzhen Salubris Pharmaceuticals

Update in progress

002294.SZ (Shenzhen)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Shenzhen Salubris Pharmaceuticals Co., Ltd. develops, makes, and sells medicines and medical devices in China. It covers therapeutic areas such as thrombosis, hypertension, osteoporosis, infections, and related conditions, plus anti-osteolysis, antiallergic, antiepileptic, and antidepressant therapies. It has several products and candidates in various trial phases for hypertension, heart failure, diabetes, hypercholesterolemia, renal anemia, and osteoporosis, and also pursues medical devices. Founded in 1998, based in Shenzhen; a subsidiary of Salubris Pharmaceuticals.

Company score

Sentiment: -0.36; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.00; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.00; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: -0.18; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive